New Blood Test Helps Detect Lynch Syndrome Earlier
新型血液檢測有助於更早發現林奇氏症候群
Lynch syndrome is an inherited condition that significantly increases the risk of developing cancers, such as colorectal and endometrial cancer, often at a young age.
林奇綜合症是一種遺傳性疾病，會顯著增加罹患癌症的風險，例如結直腸癌和子宮內膜癌，且發病年齡往往較輕。
Currently, about 95% of people with Lynch syndrome are unaware they carry it, as it remains "silent" until cancer appears.
目前，約有 95% 的林奇綜合症患者並不知道自己帶有該基因，因為它在癌症出現之前一直處於「靜默」狀態。
A major breakthrough from the University of Texas MD Anderson Cancer Center, published in Nature Communications, offers a potential solution.
德州大學 MD 安德森癌症中心在《自然通訊》期刊上發表的一項重大突破，提供了一種潛在的解決方案。
Researchers have identified a new blood-based biomarker that detects unique "immune signatures" caused by Lynch syndrome.
研究人員發現了一種新的血液生物標記，能檢測由林奇綜合症引起的獨特「免疫特徵」。
By analyzing T cell receptors, this test identifies how the body responds to specific DNA mutations.
透過分析 T 細胞受體，該測試能識別身體如何對特定的 DNA 突變做出反應。
While the current "gold standard" for diagnosis remains germline genetic testing, this new non-invasive method represents a shift toward proactive health.
雖然目前診斷的「黃金標準」仍然是生殖系基因檢測，但這種新的非侵入性方法代表了向主動健康管理的轉變。
